Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nukkleus (NUKK) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for Nukkleus (NUKK) over the last 5 years, with Q2 2025 value amounting to $5.2 million.

  • Nukkleus' Shares Outstanding (Weighted Average) rose 19269.86% to $5.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.2 million, marking a year-over-year increase of 19269.86%. This contributed to the annual value of $2.0 million for FY2024, which is 6230.24% up from last year.
  • Latest data reveals that Nukkleus reported Shares Outstanding (Weighted Average) of $5.2 million as of Q2 2025, which was up 19269.86% from $5.0 million recorded in Q1 2025.
  • Nukkleus' Shares Outstanding (Weighted Average)'s 5-year high stood at $10.6 million during Q4 2023, with a 5-year trough of $1.3 million in Q3 2023.
  • In the last 5 years, Nukkleus' Shares Outstanding (Weighted Average) had a median value of $5.9 million in 2022 and averaged $6.1 million.
  • As far as peak fluctuations go, Nukkleus' Shares Outstanding (Weighted Average) plummeted by 8711.25% in 2023, and later surged by 19269.86% in 2025.
  • Quarter analysis of 5 years shows Nukkleus' Shares Outstanding (Weighted Average) stood at $6.1 million in 2021, then surged by 64.86% to $10.1 million in 2022, then increased by 4.85% to $10.6 million in 2023, then crashed by 80.65% to $2.0 million in 2024, then skyrocketed by 156.71% to $5.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $5.2 million for Q2 2025, versus $5.0 million for Q1 2025 and $2.0 million for Q3 2024.